Literature DB >> 9572681

Elevated nerve growth factor levels in the synovial fluid of patients with inflammatory joint disease.

D A Halliday1, C Zettler, R A Rush, R Scicchitano, J D McNeil.   

Abstract

A novel pH shock extraction procedure was used to measure nerve growth factor (NGF) levels in both normal and inflamed synovial fluids using a sensitive and specific two-site enzyme linked immunosorbant assay. To date no data is available on NGF levels in normal synovial fluids. Synovial fluids were taken from 5 normal volunteers, 12 patients with rheumatoid arthritis and 10 patients with other inflammatory arthropathies. The mean +/- SEM NGF concentration in normal synovial fluids was 95 +/- 33.2 pg/ml (range 39.1-143.1 pg/ml), whereas the mean NGF concentration in the synovial fluids taken from patients with rheumatoid arthritis was 532.5 +/- 123.8 pg/ml (range 152-1686 pg/ml). The mean NGF concentration in patients with other inflammatory arthropathies was also raised (430.6 +/- 90 pg/ml; range 89-1071 pg/ml). The NGF concentrations were significantly higher in the synovial fluids from both inflamed groups (ANOVA p < 0.05) compared to normals. Raised levels of NGF in synovial fluid may contribute directly to joint inflammation via activation of inflammatory cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572681     DOI: 10.1023/a:1022475432077

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  25 in total

1.  Denervation, but not decentralization, reduces nerve growth factor content of the mesenteric artery.

Authors:  D T Liu; M T Reid; D C Bridges; R A Rush
Journal:  J Neurochem       Date:  1996-06       Impact factor: 5.372

Review 2.  Contribution of the nervous system to the pathophysiology of rheumatoid arthritis and other polyarthritides.

Authors:  J D Levine; E J Goetzl; A I Basbaum
Journal:  Rheum Dis Clin North Am       Date:  1987-08       Impact factor: 2.670

3.  Neuropeptides in synovium of patients with rheumatoid arthritis and osteoarthritis.

Authors:  M Grönblad; Y T Konttinen; O Korkala; P Liesi; M Hukkanen; J M Polak
Journal:  J Rheumatol       Date:  1988-12       Impact factor: 4.666

4.  The substance P fragment SP-(7-11) increases prostaglandin E2, intracellular Ca2+ and collagenase production in bovine articular chondrocytes.

Authors:  D A Halliday; J D McNeil; W H Betts; R Scicchitano
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

5.  Nerve growth factor (NGF) regulates tachykinin gene expression and biosynthesis in rat sensory neurons during early postnatal development.

Authors:  H Vedder; H U Affolter; U Otten
Journal:  Neuropeptides       Date:  1993-06       Impact factor: 3.286

6.  Mast cells synthesize, store, and release nerve growth factor.

Authors:  A Leon; A Buriani; R Dal Toso; M Fabris; S Romanello; L Aloe; R Levi-Montalcini
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  Biological importance of the retrograde axonal transport of nerve growth factor in sensory neurons.

Authors:  M Goedert; K Stoeckel; U Otten
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

8.  The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule.

Authors:  S B McMahon; D L Bennett; J V Priestley; D L Shelton
Journal:  Nat Med       Date:  1995-08       Impact factor: 53.440

9.  Natural autoantibodies against the nerve growth factor in autoimmune diseases.

Authors:  E Dicou; D Hurez; V Nerrière
Journal:  J Neuroimmunol       Date:  1993-09       Impact factor: 3.478

10.  Studies on carrageenan-induced arthritis in adult rats: presence of nerve growth factor and role of sympathetic innervation.

Authors:  L Aloe; M A Tuveri; R Levi-Montalcini
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

View more
  26 in total

Review 1.  Neurotrophins and the immune system.

Authors:  José A Vega; Olivia García-Suárez; Jonas Hannestad; Marta Pérez-Pérez; Antonino Germanà
Journal:  J Anat       Date:  2003-07       Impact factor: 2.610

Review 2.  Peripheral mechanisms of pain and analgesia.

Authors:  Christoph Stein; J David Clark; Uhtaek Oh; Michael R Vasko; George L Wilcox; Aaron C Overland; Todd W Vanderah; Robert H Spencer
Journal:  Brain Res Rev       Date:  2008-12-31

Review 3.  Cardiovascular actions of neurotrophins.

Authors:  Andrea Caporali; Costanza Emanueli
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

4.  Potential mechanisms for hypoalgesia induced by anti-nerve growth factor immunoglobulin are identified using autoimmune nerve growth factor deprivation.

Authors:  E M Hoffman; Z Zhang; M B Anderson; R Schechter; K E Miller
Journal:  Neuroscience       Date:  2011-07-28       Impact factor: 3.590

5.  Tanezumab for the treatment of pain from osteoarthritis of the knee.

Authors:  Nancy E Lane; Thomas J Schnitzer; Charles A Birbara; Masoud Mokhtarani; David L Shelton; Mike D Smith; Mark T Brown
Journal:  N Engl J Med       Date:  2010-09-29       Impact factor: 91.245

Review 6.  Towards a mechanism-based approach to pain management in osteoarthritis.

Authors:  Anne-Marie Malfait; Thomas J Schnitzer
Journal:  Nat Rev Rheumatol       Date:  2013-09-17       Impact factor: 20.543

Review 7.  Pain and immunity: implications for host defence.

Authors:  Pankaj Baral; Swalpa Udit; Isaac M Chiu
Journal:  Nat Rev Immunol       Date:  2019-07       Impact factor: 53.106

8.  Measurements in the Blood of BDNF for RA Patients and in Response to Anti-TNF Treatment Help Us to Clarify the Magnitude of Centrally Related Pain and to Explain the Relief of This Pain upon Treatment.

Authors:  Sture Forsgren; Ola Grimsholm; Tore Dalén; Solbritt Rantapää-Dahlqvist
Journal:  Int J Inflam       Date:  2011-06-08

9.  Increased nerve growth factor expression in the synovial tissues of patients with rotator cuff tears.

Authors:  Ryo Tazawa; Tomonori Kenmoku; Kentaro Uchida; Lars Arendt-Nielsen; Naoshige Nagura; Mitsufumi Nakawaki; Toshihide Matsumoto; Gen Inoue; Hiroto Takeuchi; Takenori Jimbo; Toshiyuki Nakazawa; Michinari Fukuda; Masashi Takaso
Journal:  Mol Pain       Date:  2021 Jan-Dec       Impact factor: 3.395

10.  Immune biomarker response depends on choice of experimental pain stimulus in healthy adults: a preliminary study.

Authors:  Yenisel Cruz-Almeida; Christopher D King; Shannon M Wallet; Joseph L Riley
Journal:  Pain Res Treat       Date:  2012-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.